These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12774389)
1. [The measurement of tyrosine hydroxylase activity in the brain of conscious rats]. Wang W; Zhao DZ; Wang WX; Sun BH Zhongguo Zhong Yao Za Zhi; 2002 Feb; 27(2):132-5. PubMed ID: 12774389 [TBL] [Abstract][Full Text] [Related]
2. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. Westerink BH; De Vries JB; Duran R J Neurochem; 1990 Feb; 54(2):381-7. PubMed ID: 1967629 [TBL] [Abstract][Full Text] [Related]
3. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum. Guo X; Chen LJ; Buda M; Jin GZ Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):289-92. PubMed ID: 1360740 [TBL] [Abstract][Full Text] [Related]
4. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis. Cumming P; Ase A; Kuwabara H; Gjedde A J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841 [TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. Cumming P; Ase A; Laliberté C; Kuwabara H; Gjedde A J Cereb Blood Flow Metab; 1997 Nov; 17(11):1254-60. PubMed ID: 9390657 [TBL] [Abstract][Full Text] [Related]
6. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine. Bongiovanni R; Young D; Newbould E; Jaskiw GE Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. Glavan G; Zivin M Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820 [TBL] [Abstract][Full Text] [Related]
8. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related]
9. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters. Vriend J; Dreger L Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138 [TBL] [Abstract][Full Text] [Related]
10. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus. Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483 [TBL] [Abstract][Full Text] [Related]
11. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes. Bräutigam M; Kittner B; Laschinski G Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908 [TBL] [Abstract][Full Text] [Related]
12. Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC. Cannazza G; Di Stefano A; Mosciatti B; Braghiroli D; Baraldi M; Pinnen F; Sozio P; Benatti C; Parenti C J Pharm Biomed Anal; 2005 Jan; 36(5):1079-84. PubMed ID: 15620535 [TBL] [Abstract][Full Text] [Related]
14. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats. Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease. Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103 [TBL] [Abstract][Full Text] [Related]
16. Repeated cocaine injections have no influence on tyrosine hydroxylase activity in the rat nucleus accumbens core or shell. Licata SC; Pierce RC Brain Res; 2004 Jun; 1012(1-2):119-26. PubMed ID: 15158168 [TBL] [Abstract][Full Text] [Related]
17. In vivo effect of apomorphine and haloperidol on MPP neurotoxicity. Espinosa-Oliva AM; de Pablos RM; Santiago M Pharmacology; 2014; 93(3-4):101-7. PubMed ID: 24556705 [TBL] [Abstract][Full Text] [Related]
18. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats. Matsushita N; Misu Y; Goshima Y Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057 [TBL] [Abstract][Full Text] [Related]
19. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat. Hedner T; Lundborg P Med Biol; 1981 Aug; 59(4):212-23. PubMed ID: 6803074 [TBL] [Abstract][Full Text] [Related]
20. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo. Carboni E; Tanda G; Di Chiara G J Neurochem; 1992 Dec; 59(6):2230-6. PubMed ID: 1431903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]